SK17994A3 - Usage of a peptidoglycan monomer, its n-acyl derivatives and its metal complexes in the preparation of medicaments - Google Patents

Usage of a peptidoglycan monomer, its n-acyl derivatives and its metal complexes in the preparation of medicaments Download PDF

Info

Publication number
SK17994A3
SK17994A3 SK179-94A SK17994A SK17994A3 SK 17994 A3 SK17994 A3 SK 17994A3 SK 17994 A SK17994 A SK 17994A SK 17994 A3 SK17994 A3 SK 17994A3
Authority
SK
Slovakia
Prior art keywords
pgm
use according
halothane
immunosuppressive
anesthesia
Prior art date
Application number
SK179-94A
Other languages
English (en)
Slovak (sk)
Inventor
Biserka Radosevic-Stasic
Bozidar Suskovic
Radmila Nauski
Danijel Rukavina
Original Assignee
Pliva Handels Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Handels Gmbh filed Critical Pliva Handels Gmbh
Publication of SK17994A3 publication Critical patent/SK17994A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SK179-94A 1991-08-15 1992-08-13 Usage of a peptidoglycan monomer, its n-acyl derivatives and its metal complexes in the preparation of medicaments SK17994A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YU141291 1991-08-15
PCT/EP1992/001859 WO1993003746A1 (fr) 1991-08-15 1992-08-13 Preparation de medicaments contenant le monomere de peptidoglycane ou ses derives

Publications (1)

Publication Number Publication Date
SK17994A3 true SK17994A3 (en) 1994-08-10

Family

ID=25554075

Family Applications (1)

Application Number Title Priority Date Filing Date
SK179-94A SK17994A3 (en) 1991-08-15 1992-08-13 Usage of a peptidoglycan monomer, its n-acyl derivatives and its metal complexes in the preparation of medicaments

Country Status (10)

Country Link
EP (1) EP0600974A1 (fr)
JP (1) JPH08506796A (fr)
BG (1) BG98628A (fr)
CA (1) CA2115270A1 (fr)
CZ (1) CZ30194A3 (fr)
HR (1) HRP920488A2 (fr)
HU (1) HU9400420D0 (fr)
RU (1) RU94027699A (fr)
SK (1) SK17994A3 (fr)
WO (1) WO1993003746A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU45382B (en) * 1986-11-19 1992-05-28 Pliva Sour Zagreb Process for preparing complex of n-acethyl-glucosis-aminyl-n-acethyl-muramoil-l-alanyl-d-izoglutaminyl-(l)-mezodiaminopimelyl-(d-amid)-(l)-al
US4868155A (en) * 1987-10-05 1989-09-19 Merck & Co., Inc. Dipeptidyl 4-0-,6-0-acyl-2-amino-2-deoxy-D-glucose compositions and methods of use in AIDS-immunocompromised human hosts
YU62689A (en) * 1989-03-27 1991-02-28 Pliva Pharm & Chem Works N-acyl derivatives of peptidoglican monomer, their pharmaceutically acceptable salts, process for preparing thereof and their use as immunity modulators and immunoadjuvant

Also Published As

Publication number Publication date
CA2115270A1 (fr) 1993-03-04
EP0600974A1 (fr) 1994-06-15
BG98628A (en) 1995-06-30
WO1993003746A1 (fr) 1993-03-04
JPH08506796A (ja) 1996-07-23
CZ30194A3 (en) 1994-06-15
HU9400420D0 (en) 1994-08-29
RU94027699A (ru) 1996-04-10
HRP920488A2 (en) 1994-08-31

Similar Documents

Publication Publication Date Title
US4815446A (en) Process for treating metastasis of cancerous tumors
US4760053A (en) Combination therapy for selected sex steroid dependent cancers
US4775661A (en) Combination therapy for treatment of female breast cancer
US4775660A (en) Treatment of breast cancer by combination therapy
US4717716A (en) Immuno-regulator
SK138597A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
EP0563127B1 (fr) Procede ameliore de traitement du cancer
Butler et al. Ovine placental lactogen stimulation of ornithine decarboxylase activity in brain and liver of neonatal rats
DE19910682A1 (de) Kombination von Fibraten mit einem oder mehreren Wirkstoffen, die den Homocysteinspiegel zu senken vermögen
JP3470901B2 (ja) Ｅｌｆ５Ａ生合成の抑制方法
EP0729362B1 (fr) PREPARATION TRANSDERMIQUE DE N- N- 5- 4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-alpha-ASPARTYL]-L-PHENYLALANINE OU DE SES ESTERS ET DE LEURS SELS ACCEPTABLES PHARMACEUTIQUEMENT
SK17994A3 (en) Usage of a peptidoglycan monomer, its n-acyl derivatives and its metal complexes in the preparation of medicaments
SK164695A3 (en) Use of ropivacaine in the manufacture of a pharmaceutical agent with analgetic effect with minimal motor blockade
US7906486B2 (en) Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa
JPH11511479A (ja) １，２，４−ベンゾトリアジンオキシド製剤
US2683106A (en) Analgesic composition
EP0372676A1 (fr) Préparation thérapeutique et procédé
EP0728479A1 (fr) Désacétyl moxisylyte dans le traitement des rétentions aigues d'urine
US3129137A (en) Method of inhibiting gastro-intestinal irritation
JPS63503542A (ja) 新規組成物
NZ226915A (en) Cancer treatment composition comprising of a mixture of vincristine and a peptide
Davis et al. Normal and promoted GI absorption of water-soluble substances II: Absorption of vitamin B12 from ligated stomach and intact intestine of the rat
RU2071767C1 (ru) Способ лечения онкологических больных
EP0672420A1 (fr) Substance guerissant les blessures
TAMAKI et al. Intestinal Absorption of a New Anticholinergic Agent, Timepidium Bromide. II. Enhancement of Absorption